The fate of acute myocarditis between spontaneous improvement and evolution to dilated cardiomyopathy: A review

Heart

Volumn 85, Issue 5, 2001, Pages 499-504

  D'Ambrosio, A ^a   Patti, G ^a   Manzoli, A ^a   Di Sciascio, G ^a   Sinagra, G ^b   Di Lenarda, A ^b   Silvestri, F ^c  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^b Cardiology Division and University   (Italy)

^c Cancer Registry Prov of Trieste   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE DISEASE; CLINICAL FEATURE; DISEASE COURSE; HEART DILATATION; HUMAN; MOLECULAR BIOLOGY; MYOCARDITIS; PRIORITY JOURNAL; PROGNOSIS; REMISSION; REVIEW; TREATMENT OUTCOME;

EID: 0034763492     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/heart.85.5.499     Document Type: Review

References (71)

1. Report of the 1995 World Health Organisation/International Society and Federation of Cardiology task force on the definition and classification of cardiomyopathies
2. Enteroviral myocarditis and dilated cardiomyopathy: A review of clinical and experimental studies
3. Essai sur les maladies et les lesions organisque du coeur
4. Endomyocardial biopsy
5. Myocarditis: A histopathological definition and classification
6. Animal models: Pathological findings and therapeutic considerations
7. Biology of disease. Animal models of picornavirus-induced autoimmune disease: Their possible relevance to human disease
8. Immunosuppressive and immunomodulatory treatment for myocarditis
9. Viral myocarditis: A paradigm for understanding the pathogenesis and treatment of dilated cardiomyopathy
10. Detection of coxsackie-B-virus-specific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy
11. Myocarditis - Continuing clinical and pathologic confusion
12. Long-term follow up of acute myocarditis. Correlation of ventricular function and outcome
13. Active myocarditis in the spectrum of acute dilated cardiomyopathies
14. Interobserver variability in the pathologic interpretation of endomyocardial biopsy results
15. Evaluation of postmortem endomyocardial biopsy specimens from 38 patients with lymphocytic myocarditis: Implications for role of sampling error
16. Absence of evidence of myocarditis in endomyocardial biopsy specimen from patients with dilated (congestive) cardiomyopathy
17. Natural history of acute viral or idiopathic myocarditis: A clinical and endomyocardial biopsy follow-up
18. Polimorfismo clinico di presentazione e storia naturale della miocardite attiva: Esperienza su 60 casi
19. Myocarditis confirmed by biopsy presenting as acute myocardial infarction
20. Viral myocarditis mimicking acute myocardial infarction
21. Diagnosis and classification of myocarditis by endomyocardial biopsy
22. Children may survive myocarditis with prolonged use of biventricular assist devices
23. Lymphocytic myocarditis presenting as unexplained ventricular arrhythmias: Diagnosis with endomyocardial biopsy and response to immunosuppression
24. The long-term prognosis in acute myocarditis
25. The role of biopsy in the diagnosis and follow up of myocarditis: A critical review
26. Immunosuppressive treatment for myocarditis and dilated cardiomyopathy
27. A clinical trial of immunosuppressive therapy for myocarditis
28. Viral myocarditis
29. An animal model of congestive (dilated) cardiomyopathy: Dilation and hypertrophy of the heart in chronic stage in DBA/2 mice with myocarditis caused by encephalomyocarditis virus
30. Five-year follow up study of cases suggestive of acute myocarditis
31. Cardiac manifestations during a coxsackie B5 epidemic
32. Adult heart disease due to coxsackie virus B infection
33. Coxsackie B myopericarditis in adults
34. Acute myocarditis: A follow up study
35. Coxsackie virus heart disease and cardiomyopathy
36. Secondary myocardial disease. Virus myocarditis and cardiomyopathy
37. Diagnosis of active lymphocytic myocarditis by endomyocardial biopsy. Quantitative criteria for light microscopy
38. A long term follow-up study of acute viral and idiopathic myocarditis
39. A long-term follow-up study of acute myocarditis: An electrocardiographic and echocardiographic study
40. Acute myocarditis. Role of histological and virological examination in the diagnosis and assessment of immunosuppressive treatment
41. Long-term follow-up of patients with previous myocarditis using radionuclide ventriculography
42. The morphological progression of viral myocarditis
43. Natural history of untreated chronic myocarditis (active myocarditis with fibrosis)
44. Immunosuppressive therapy of myocardial inflammatory disease - Initial experience and further trials to define indications for therapy
45. Clinical presentation and evolution in treated and untreated myocarditis
46. Giant cell versus lymphocytic myocarditis: A comparison of their clinical features and long term outcomes
47. Prognosis of patients with acute viral myocarditis in whom endomyocardial biopsies and/or autopsies were performed: An ISFC survey
48. Immunosuppressive treatment in autoreactive myocarditis - Results from a controlled trial
49. Long term follow-up of electrocardiographic findings in patients with acute myocarditis proven by endomyocardial biopsy
50. Viral and idiopathic myocarditis in Japan: A questionnaire survey
51. Clinical presentation and predictive factors of long term outcome in patients with biopsy-proven myocarditis
52. Demographic features and prevalence of idiopathic myocarditis in patients undergoing endomyocardial biopsy
53. Antibodies to coxsackie B viruses in congestive cardiomyopathy
54. Detection of coxsackie B3 RNA in myocardial tissues by polymerase chain reaction
55. Similar prevalence of enteroviral genome within the myocardium from patients with idiopathic dilated cardiomyopathy and controls by polymerase chain reaction
56. Low frequency of detection by nested polymerase chain reaction of enterovirus ribonucleic acid in endomyocardial tissue of patients with idiopathic dilated cardiomyopathy
57. Coxsackie virus heart diseases: 15 Years after
58. Clinical outcome and left ventricular function 23 years after acute coxsackie virus myopericarditis
59. Relation between histological findings on early repeat right ventricular biopsy and ventricular function in patients with myocarditis
60. Long-term outcome of patients with biopsy-proved myocarditis: Comparison with idiopathic dilated cardiomyopathy
61. Predictors of adverse outcome in biopsy-proven myocarditis
62. Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis
63. Electrocardiography of myocarditis revisited: Clinical and prognostic significance of electrocardiographic changes
64. Haemodynamic findings in biopsy proven acute myocarditis
65. Presence of poorly stained myocytes in acute myocarditis predicts improvement in cardiac function
66. End-stage dilated cardiomyopathy persistence of enterovirus RNA in myocardium at cardiac transplantation and lack of immune response
67. Enterovirus RNA sequences in hearts with dilated cardiomyopathy: A pathogenic link between virus infection and dilated cardiomyopathy
68. Clinical and prognostic relevance of detection of enteroviral RNA in the myocardium of patients with myocarditis or dilated cardiomyopathy
69. Myocardial enterovirus infection with left ventricular dysfunction: A benign disease compared with idiopathic dilated cardiomyopathy
70. Persistence of enterovirus RNA in chronic fatigue syndrome is associated with the abnormal production of equal amounts of positive and negative strands of enteroviral RNA
71. Selective gene expression in the failing human heart